ibuprofen has been researched along with Candidiasis, Chronic Mucocutaneous in 1 studies
Midol: combination of cinnamedrine, phenacetin, aspirin & caffeine
Candidiasis, Chronic Mucocutaneous: A clinical syndrome characterized by development, usually in infancy or childhood, of a chronic, often widespread candidiasis of skin, nails, and mucous membranes. It may be secondary to one of the immunodeficiency syndromes, inherited as an autosomal recessive trait, or associated with defects in cell-mediated immunity, endocrine disorders, dental stomatitis, or malignancy.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jorizzo, JL | 1 |
| Goldblum, RM | 1 |
| Daniels, JC | 1 |
| Ichikawa, Y | 1 |
| Langford, MP | 1 |
| Fagan, KM | 1 |
1 other study available for ibuprofen and Candidiasis, Chronic Mucocutaneous
| Article | Year |
|---|---|
Evaluation of immune-enhancing effects of ibuprofen in an immunodeficiency model.
Topics: Candidiasis; Candidiasis, Chronic Mucocutaneous; Cyclooxygenase Inhibitors; Humans; Ibuprofen; Immun | 1985 |